Details for Patent: 10,039,728
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
Which drugs does patent 10,039,728 protect, and when does it expire?
Patent 10,039,728 protects EPINEPHRINE and is included in one NDA.
Summary for Patent: 10,039,728
| Title: | More potent and less toxic formulations of epinephrine and methods of medical use |
| Abstract: | The present invention provides pharmaceutical formulations of levorotatory-epinephrine, 1-epinephrine, more potent and less toxic than existing pharmaceutical formulations of epinephrine, along with methods of producing and using these pharmaceutical formulations of 1-epinephrine, including providing prefilled syringes of pharmaceutical formulations of 1-epinephrine and methods of using these prefilled syringes by treating patients with continuous intravenous infusion instead of bolus administration. |
| Inventor(s): | Taneja; Jugal K. (Tampa, FL) |
| Assignee: | |
| Application Number: | 15/616,157 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,039,728 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 10,039,728
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bpi Labs | EPINEPHRINE | epinephrine | SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | 205029-001 | Jul 29, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | INCREASING MEAN ARTERIAL BLOOD PRESSURE IN ADULT PATIENTS WITH HYPOTENSION ASSOCIATED WITH SEPTIC SHOCK | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
